Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens

Annals of Clinical Microbiology and Antimicrobials

Volumn 10, Issue , 2011, Pages

  Kouidhi, Bochra ^a   Zmantar, Tarek ^a   Jrah, Hanene ^a   Souiden, Yosra ^b   Chaieb, Kamel ^a   Mahdouani, Kacem ^b   Bakhrouf, Amina ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Kairouan Hospital   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; TETRACYCLINE; THYMOQUINONE; ANTIINFECTIVE AGENT; BENZOQUINONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; NONHUMAN; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH; MOUTH DISEASE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BENZOQUINONES; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH; MOUTH DISEASES;

EID: 79959535843     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-10-29     Document Type: Article

References (35)

1. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival plaque. J Bacteriol 2001, 183:3770-3783. 10.1128/JB.183.12.3770-3783.2001, 95255, 11371542.
2. Barrau K, Boulamery A, Imbert G, Casalta JP, Habib G, Messana T, Bonnet JL, Rubinstein E, Raoult D. Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect 2004, 10:302-308. 10.1111/j.1198-743X.2004.00776.x, 15059118.
3. Mojon P, Bourbeau J. Respiratory infection: how important is oral health?. Curr Opin Pulm Med 2003, 9:166-170. 10.1097/00063198-200305000-00002, 12682559.
4. Okuda K, Kato T, Ishihara K. Involvement of periodontopathic biofilm in vascular diseases. Oral Dis 2004, 10:5-12. 10.1046/j.1354-523X.2003.00979.x, 14996287.
5. Hamada S, Koga T, Ooshima T. Virulence factors of Streptococcus mutans and dental caries prevention. J Dent Res 1984, 63:407-411. 10.1177/00220345840630031001, 6230378.
6. Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986, 50:353-380. 373078, 3540569.
7. Kouidhi B, Zmantar T, Hentati H, Najjari F, Mahdouni K, Bakhrouf A. Molecular investigation of macrolide and Tetracycline resistances in oral bacteria isolated from Tunisian children. Arch Oral Biol 2011, 56:127-135. 10.1016/j.archoralbio.2010.09.010, 20950793.
8. Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice--a cause for concern?. J Antimicrob Chemother 2004, 53:567-576. 10.1093/jac/dkh137, 14985274.
9. Marshall NJ, Piddock LJ. Antibacterial efflux systems. Microbiologia 1997, 13:285-300.
10. Pai MR, Acharya LD, Udupa N. Evaluation of antiplaque activity of Azadirachta indica leaf extract gel--a 6-week clinical study. J Ethnopharmacol 2004, 90:99-103. 10.1016/j.jep.2003.09.035, 14698516.
11. Phillips JD. Medicinal plants. Biologist 1992, 39:187-191.
12. Abu-Irmaileh BE, Afifi FU. Herbal medicine in Jordan with special emphasis on commonly used herbs. J Ethnopharmacol 2003, 89:193-197. 10.1016/S0378-8741(03)00283-6, 14611882.
13. Ferdous AJ, Islam SN, Ahsan M, Hasan CM, Ahmed ZU. In vitro antibacterial activity of the volatile oil of Nigella sativa seeds against multiple drug-resistant isolates of Shigella spp. and isolates of Vibrio cholerae and Escherichia coli. Phytotherapy Research 2006, 6:137-140.
14. Hanafy MS, Hatem ME. Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J Ethnopharmacol 1991, 34:275-278. 10.1016/0378-8741(91)90047-H, 1795532.
15. Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res 1998, 18:1527-1532.
16. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie 2000, 55:379-382.
17. El-Dakhakhany M. Studies on the chemical constitution of Egyptian N. sativa L. seeds. Planta Medica 1963, 11:465-470.
18. Halawani E. Antibacterial Acativity of Thymoquinone and Thymohydroquinone of Nigella sativa L. and Their Interaction with Some Antibiotics. Advances in Biological Research 2009, 3:148-152.
19. Gibbons S, Oluwatuyi M, Kaatz GW. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 2003, 51:13-17.
20. Oluwatuyi M, Kaatz GW, Gibbons S. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 2004, 65:3249-3254. 10.1016/j.phytochem.2004.10.009, 15561190.
21. Falcao-Silva VS, Silva DA, Souza Mde F, Siqueira-Junior JP. Modulation of drug resistance in Staphylococcus aureus by a kaempferol glycoside from Herissantia tiubae (Malvaceae). Phytother Res 2009, 23:1367-1370. 10.1002/ptr.2695, 19224523.
22. Fernandes Junior A, Balestrin EC, Betoni JE, Orsi Rde O, da Cunha Mde L, Montelli AC. Propolis: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem Inst Oswaldo Cruz 2005, 100:563-566. 10.1590/S0074-02762005000500018, 16302067.
23. Al-hebshi N, Al-haroni M, Skaug N. In vitro antimicrobial and resistance-modifying activities of aqueous crude khat extracts against oral microorganisms. Arch Oral Biol 2006, 51:183-188. 10.1016/j.archoralbio.2005.08.001, 16248981.
24. CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard - Seventh Edition CLSI Document M7-A7 2006, CLSI.
25. Magina MD, Dalmarco EM, Wisniewski A, Simionatto EL, Dalmarco JB, Pizzolatti MG, Brighente IM. Chemical composition and antibacterial activity of essential oils of Eugenia species. J Nat Med 2009, 63:345-350. 10.1007/s11418-009-0329-5, 19308653.
26. Lee EW, Chen J, Huda MN, Kuroda T, Mizushima T, Tsuchiya T. Functional cloning and expression of emeA, and characterization of EmeA, a multidrug efflux pump from Enterococcus faecalis. Biol Pharm Bull 2003, 26:266-270. 10.1248/bpb.26.266, 12576692.
27. Morita Y, Komori Y, Mima T, Kuroda T, Mizushima T, Tsuchiya T. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump. FEMS Microbiol Lett 2001, 202:139-143. 10.1111/j.1574-6968.2001.tb10794.x, 11506922.
28. Tanaka S, Lerner SA, Lin EC. Replacement of a phosphoenolpyruvate-dependent phosphotransferase by a nicotinamide adenine dinucleotide-linked dehydrogenase for the utilization of mannitol. J Bacteriol 1967, 93:642-648. 276489, 4289962.
29. Berger EA. Different mechanisms of energy coupling for the active transport of proline and glutamine in Escherichia coli. Proc Natl Acad Sci USA 1973, 70:1514-1518. 10.1073/pnas.70.5.1514, 433532, 4268097.
30. Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 2007, 59:1247-1260. 10.1093/jac/dkl460, 17145734.
31. Markham PN. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrob Agents Chemother 1999, 43:988-989. 89246, 10103220.
32. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006, 19:382-402. 10.1128/CMR.19.2.382-402.2006, 1471989, 16614254.
33. Chen J, Morita Y, Huda MN, Kuroda T, Mizushima T, Tsuchiya T. VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J Bacteriol 2002, 184:572-6. 10.1128/JB.184.2.572-576.2002, 139572, 11751837.
34. Littlejohn TG, Paulsen IT, Gillespie MT, Tennent JM, Midgley M, Jones IG, Purewal AS, Skurray RA. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett 1992, 74:259-265.
35. Ogawa W, Li DW, Yu P, Begum A, Mizushima T, Kuroda T, Tsuchiya T. Multidrug Resistance in Klebsiella pneumoniae MGH78578 and Cloning of Genes Responsible for the Resistance. Biol Pharm Bull 2005, 28:1505-1508. 10.1248/bpb.28.1505, 16079502.